Clinical trials
Phase 2 Heart Failure trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 1 |
| 2020 | 1 |
| 2022 | 1 |
| 2023 | 4 |
| 2024 | 1 |
| 2025 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 3 |
| Active, not recruiting | 2 |
| Completed | 2 |
| Recruiting | 2 |
| Terminated | 2 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer | 2 |
| AstraZeneca | 1 |
| Beijing University of Chinese Medicine | 1 |
| Bristol-Myers Squibb | 1 |
| Innolife Co., Ltd. | 1 |
| Jemincare | 1 |
| Monyan Pharmaceutical (Shanghai) Co., Ltd. | 1 |
| Novartis Pharmaceuticals | 1 |
| Salubris Biotherapeutics Inc | 1 |
| Sinotau Pharmaceutical Group | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Heart Failure | 12 |
| Arrhythmias, Cardiac | 1 |
| Atrial Fibrillation | 1 |
| Atrial Flutter | 1 |
| Cardiovascular Diseases | 1 |
| Edema, Cardiac | 1 |
| Heart Failure, Diastolic | 1 |
| Heart Failure, Systolic | 1 |
| Hypertension, Pulmonary | 1 |
| Neoplasms | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.